Hartford Creative Group, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Hartford Creative Group, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jul 31, 2025 | $2.04M | Oct 15, 2025 |
| FY2025 | Jul 31, 2024 | $1.40M | Oct 15, 2025 |
| FY2019 | Jul 31, 2019 | $56.2K | Nov 14, 2019 |
| FY2019 | Jul 31, 2018 | $0 | Nov 14, 2019 |
| FY2018 | Jul 31, 2017 | $0 | Nov 14, 2018 |
| FY2017 | Jul 31, 2016 | $0 | Nov 7, 2017 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jul 31, 2025 | 279.90M | Oct 15, 2025 |
| FY2025 | Jul 31, 2025 | $38.80M | Oct 15, 2025 |
| FY2025 | Jul 31, 2024 | $13.60M | Oct 15, 2025 |
| FY2025 | Jul 31, 2024 | 98.40M | Oct 15, 2025 |
| FY2022 | Jul 31, 2022 | $561.3K | Jun 12, 2023 |
| FY2022 | Jul 31, 2021 | $553.5K | Jun 12, 2023 |
| FY2021 | Jul 31, 2020 | $98.3K | Oct 29, 2021 |
| FY2020 | Jul 31, 2019 | $56.2K | Feb 26, 2021 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Jul 31, 2021 | $245.0K | Oct 29, 2021 |
| FY2021 | Jul 31, 2020 | $12.1K | Oct 29, 2021 |
| FY2020 | Jul 31, 2019 | $44.7K | Feb 26, 2021 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jul 31, 2025 | $1.10M | Oct 15, 2025 |
| FY2025 | Jul 31, 2024 | $1.09M | Oct 15, 2025 |
| FY2024 | Jul 31, 2023 | $396.9K | Oct 29, 2024 |
| FY2023 | Jul 31, 2022 | ($1.58M) | Oct 30, 2023 |
| FY2022 | Jul 31, 2021 | ($2.25M) | Jun 12, 2023 |
| FY2021 | Jul 31, 2020 | ($2.65M) | Oct 29, 2021 |
| FY2020 | Jul 31, 2019 | ($584.2K) | Feb 26, 2021 |
| FY2019 | Jul 31, 2018 | ($25.4K) | Nov 14, 2019 |
| FY2018 | Jul 31, 2017 | ($19.9K) | Nov 14, 2018 |
| FY2017 | Jul 31, 2016 | ($28.4K) | Nov 7, 2017 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jul 31, 2025 | $1.23M | Oct 15, 2025 |
| FY2025 | Jul 31, 2024 | $1.10M | Oct 15, 2025 |
| FY2024 | Jul 31, 2023 | ($123.7K) | Oct 29, 2024 |
| FY2023 | Jul 31, 2022 | ($177.9K) | Oct 30, 2023 |
| FY2022 | Jul 31, 2021 | ($255.7K) | Jun 12, 2023 |
| FY2021 | Jul 31, 2020 | ($3.50M) | Oct 29, 2021 |
| FY2020 | Jul 31, 2019 | ($682.5K) | Feb 26, 2021 |
| FY2019 | Jul 31, 2018 | ($25.6K) | Nov 14, 2019 |
| FY2018 | Jul 31, 2017 | ($19.6K) | Nov 14, 2018 |
| FY2017 | Jul 31, 2016 | ($28.4K) | Nov 7, 2017 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Jul 31, 2018 | $3.4K | Nov 14, 2018 |
| FY2018 | Jul 31, 2017 | $2.2K | Nov 14, 2018 |
| FY2017 | Jul 31, 2016 | $9.0K | Nov 7, 2017 |
| FY2016 | Jul 31, 2015 | $4.6K | Nov 9, 2016 |
| FY2015 | Jul 31, 2014 | $1.4K | Nov 13, 2015 |
| FY2013 | Jul 31, 2013 | $1.1K | Nov 12, 2013 |
| FY2013 | Jul 31, 2012 | $805 | Nov 12, 2013 |
| FY2012 | Jul 31, 2011 | $919 | Oct 31, 2012 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jul 31, 2025 | $697.4K | Oct 15, 2025 |
| FY2025 | Jul 31, 2024 | $247.9K | Oct 15, 2025 |
| FY2024 | Jul 31, 2023 | $123.7K | Oct 29, 2024 |
| FY2023 | Jul 31, 2022 | $177.9K | Oct 30, 2023 |
| FY2022 | Jul 31, 2021 | $255.7K | Jun 12, 2023 |
| FY2021 | Jul 31, 2020 | $1.81M | Oct 29, 2021 |
| FY2020 | Jul 31, 2019 | $713.5K | Feb 26, 2021 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jul 31, 2025 | ($13.1K) | Oct 15, 2025 |
| FY2025 | Jul 31, 2024 | $859.0K | Oct 15, 2025 |
| FY2024 | Jul 31, 2023 | ($123.4K) | Oct 29, 2024 |
| FY2023 | Jul 31, 2022 | ($860.8K) | Oct 30, 2023 |
| FY2022 | Jul 31, 2021 | ($2.38M) | Jun 12, 2023 |
| FY2021 | Jul 31, 2020 | ($1.40M) | Oct 29, 2021 |
| FY2020 | Jul 31, 2019 | ($1.26M) | Feb 26, 2021 |
| FY2019 | Jul 31, 2018 | ($26.4K) | Nov 14, 2019 |
| FY2018 | Jul 31, 2017 | ($19.6K) | Nov 14, 2018 |
| FY2017 | Jul 31, 2016 | ($25.5K) | Nov 7, 2017 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jul 31, 2025 | $319 | Oct 15, 2025 |
| FY2022 | Jul 31, 2022 | $145.0K | Jun 12, 2023 |
| FY2022 | Jul 31, 2021 | $168.3K | Jun 12, 2023 |
| FY2021 | Jul 31, 2020 | $270.8K | Oct 29, 2021 |
| FY2020 | Jul 31, 2019 | $3.7K | Feb 26, 2021 |
| FY2019 | Jul 31, 2018 | $0 | Nov 14, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jul 31, 2025 | $6.91M | Oct 15, 2025 |
| FY2025 | Jul 31, 2024 | $3.69M | Oct 15, 2025 |
| FY2024 | Jul 31, 2023 | $7.8K | Oct 29, 2024 |
| FY2023 | Jul 31, 2022 | $4.54M | Oct 30, 2023 |
| FY2022 | Jul 31, 2021 | $5.74M | Jun 12, 2023 |
| FY2021 | Jul 31, 2020 | $6.29M | Oct 29, 2021 |
| FY2020 | Jul 31, 2019 | $3.67M | Feb 26, 2021 |
| FY2019 | Jul 31, 2018 | $1.4K | Nov 14, 2019 |
| FY2018 | Jul 31, 2017 | $2.5K | Nov 14, 2018 |
| FY2017 | Jul 31, 2016 | $1.8K | Nov 7, 2017 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jul 31, 2025 | $6.61M | Oct 15, 2025 |
| FY2025 | Jul 31, 2024 | $7.04M | Oct 15, 2025 |
| FY2024 | Jul 31, 2023 | $4.50M | Oct 29, 2024 |
| FY2023 | Jul 31, 2022 | $10.97M | Oct 30, 2023 |
| FY2022 | Jul 31, 2021 | $10.73M | Jun 12, 2023 |
| FY2021 | Jul 31, 2020 | $8.58M | Oct 29, 2021 |
| FY2020 | Jul 31, 2019 | $2.42M | Feb 26, 2021 |
| FY2019 | Jul 31, 2018 | $832 | Nov 14, 2019 |
| FY2018 | Jul 31, 2017 | $23.6K | Nov 14, 2018 |
| FY2017 | Jul 31, 2016 | $3.1K | Nov 7, 2017 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jul 31, 2025 | $299.2K | Oct 15, 2025 |
| FY2025 | Jul 31, 2024 | ($3.35M) | Oct 15, 2025 |
| FY2025 | Jul 31, 2023 | ($4.49M) | Oct 15, 2025 |
| FY2024 | Jul 31, 2022 | ($6.43M) | Oct 29, 2024 |
| FY2020 | Jul 31, 2020 | ($2.29M) | Nov 10, 2020 |
| FY2020 | Jul 31, 2019 | $1.25M | Nov 10, 2020 |
| FY2020 | Jul 31, 2018 | $612 | Nov 10, 2020 |
| FY2019 | Jul 31, 2017 | ($21.2K) | Nov 14, 2019 |
| FY2018 | Jul 31, 2016 | ($1.3K) | Nov 14, 2018 |
| FY2017 | Jul 31, 2015 | $4.6K | Nov 7, 2017 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Jul 31, 2019 | $1.04M | Oct 29, 2021 |
| FY2019 | Jul 31, 2018 | $0 | Nov 14, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jul 31, 2025 | ($4.81M) | Oct 15, 2025 |
| FY2025 | Jul 31, 2024 | ($5.91M) | Oct 15, 2025 |
| FY2024 | Jul 31, 2023 | ($7.00M) | Oct 29, 2024 |
| FY2023 | Jul 31, 2022 | ($7.40M) | Oct 30, 2023 |
| FY2022 | Jul 31, 2021 | ($5.82M) | Jun 12, 2023 |
| FY2021 | Jul 31, 2020 | ($3.57M) | Oct 29, 2021 |
| FY2020 | Jul 31, 2019 | ($916.8K) | Feb 26, 2021 |
| FY2019 | Jul 31, 2018 | ($332.6K) | Nov 14, 2019 |
| FY2018 | Jul 31, 2017 | ($307.3K) | Nov 14, 2018 |
| FY2017 | Jul 31, 2016 | ($287.4K) | Nov 7, 2017 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jul 31, 2025 | $57.1K | Oct 15, 2025 |
| FY2025 | Jul 31, 2024 | $310.8K | Oct 15, 2025 |
| FY2024 | Jul 31, 2023 | $5.8K | Oct 29, 2024 |
| FY2024 | Jul 31, 2022 | $15.2K | Oct 29, 2024 |
| FY2022 | Jul 31, 2021 | $12.7K | Jun 12, 2023 |
| FY2021 | Jul 31, 2020 | $36.6K | Oct 29, 2021 |
| FY2020 | Jul 31, 2019 | $269.7K | Feb 26, 2021 |
| FY2019 | Jul 31, 2018 | $1.4K | Nov 14, 2019 |
| FY2018 | Jul 31, 2017 | $1.9K | Nov 14, 2018 |
| FY2018 | Jul 31, 2016 | $359 | Nov 14, 2018 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jul 31, 2025 | 0 | Oct 15, 2025 |
| FY2025 | Jul 31, 2024 | 0 | Oct 15, 2025 |
| FY2024 | Jul 31, 2023 | 0 | Oct 29, 2024 |
| FY2023 | Jul 31, 2022 | 0 | Oct 30, 2023 |
| FY2022 | Jul 31, 2021 | 0 | Jun 12, 2023 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jul 31, 2025 | 0 | Oct 15, 2025 |
| FY2025 | Jul 31, 2024 | 0 | Oct 15, 2025 |
| FY2024 | Jul 31, 2023 | 0 | Oct 29, 2024 |
| FY2023 | Jul 31, 2022 | 0 | Oct 30, 2023 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jul 31, 2025 | 25.03M | Oct 15, 2025 |
| FY2025 | Jul 31, 2024 | 25.03M | Oct 15, 2025 |
| FY2024 | Jul 31, 2023 | 100.11M | Oct 29, 2024 |
| FY2023 | Jul 31, 2022 | 100.11M | Oct 30, 2023 |
| FY2022 | Jul 31, 2021 | 100.11M | Jun 12, 2023 |
| FY2021 | Jul 31, 2020 | 99.11M | Oct 29, 2021 |
| FY2020 | Jul 31, 2019 | 99.11M | Feb 26, 2021 |
| FY2019 | Jul 31, 2018 | 3.02M | Nov 14, 2019 |
| FY2018 | Jul 31, 2017 | 3.02M | Nov 14, 2018 |
| FY2016 | Jul 31, 2016 | 3.02M | Nov 9, 2016 |